These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16310598)

  • 1. Preventing venous thromboembolism in the intensive care unit: A no-brainer?
    Gould MK
    J Crit Care; 2005 Dec; 20(4):304-5. PubMed ID: 16310598
    [No Abstract]   [Full Text] [Related]  

  • 2. Deep vein thrombosis in the intensive care unit: underappreciated, understudied, and undertreated.
    Shorr AF; Jackson WL
    J Crit Care; 2005 Dec; 20(4):301-3. PubMed ID: 16310597
    [No Abstract]   [Full Text] [Related]  

  • 3. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
    DeLoughery TG
    Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Venous thromboprophylaxis postcaesarean: survey of practices in Lorraine].
    Vial F; Hein F; Boileau S; Vedel M; Bouaziz H
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):395-6. PubMed ID: 19303734
    [No Abstract]   [Full Text] [Related]  

  • 5. Thromboprophylaxis for intensive care patients in Australia and New Zealand: a brief survey report.
    Cooper DJ; Bishop N; Cade J; Finfer S; Gallus A; Myburgh J;
    J Crit Care; 2005 Dec; 20(4):354-6. PubMed ID: 16310607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiency.
    Douketis JD; Rabbat C; Crowther MA;
    J Crit Care; 2005 Dec; 20(4):324-9. PubMed ID: 16310603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin for initial treatment of venous thromboembolism.
    Brewer D
    Am Fam Physician; 2005 Jul; 72(1):75-6. PubMed ID: 16035683
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evidence for thrombosis prophylaxis to high-risk patients].
    Själander A; Jansson JH; Bergqvist D; Eriksson H; Svensson P
    Lakartidningen; 2007 May 14-29; 104(20-21):1585-7. PubMed ID: 17564265
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing venous thromboembolism, especially in elderly people.
    Le Gal G; Mottier D
    Arch Intern Med; 2005 Dec 12-26; 165(22):2687. PubMed ID: 16344430
    [No Abstract]   [Full Text] [Related]  

  • 10. Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids.
    Gerhardt A; Zotz RB; Stockschlaeder M; Scharf RE
    Thromb Haemost; 2007 Mar; 97(3):496-7. PubMed ID: 17334521
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter 1: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
    Wille-Jorgensen P
    Br J Surg; 2006 Mar; 93(3):374; author reply 375-6. PubMed ID: 16498577
    [No Abstract]   [Full Text] [Related]  

  • 12. Low-molecular-weight heparins for the long-term treatment of cancer patients with venous thromboembolism.
    Prandoni P
    J Support Oncol; 2006 Mar; 4(3):127-8. PubMed ID: 16553138
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of venous thromboembolism after acute ischaemic stroke.
    Ricci S; Celani MG; Righetti E; Dennis M; Sandercock P
    Lancet; 2007 Sep; 370(9589):735-6; author reply 736-7. PubMed ID: 17765511
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter 3: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
    Agnelli G; Bergqvist D; Dahl O; Eriksson B; Rud Lassen M; Mouret P; Rosencher N
    Br J Surg; 2006 Mar; 93(3):375; author reply 375-6. PubMed ID: 16498579
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter 2: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344).
    Tangelder MJ; Bylock A; Held P
    Br J Surg; 2006 Mar; 93(3):374-5; author reply 375-6. PubMed ID: 16498578
    [No Abstract]   [Full Text] [Related]  

  • 16. Venous thromboembolism: a guide to prevention and treatment.
    Crowther M; McCourt K
    Nurse Pract; 2005 Aug; 30(8):26-9, 32-4, 39-43; quiz 44-5. PubMed ID: 16094200
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-molecular-weight heparins for the treatment of acute coronary syndrome and venous thromboembolism in patients with chronic renal insufficiency.
    Lim W; Al Saleh K; Douketis JD
    Thromb Res; 2006; 118(3):409-16. PubMed ID: 16026817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolism.
    Fitzmaurice D; Hobbs FR; McManus R
    Clin Evid; 2005 Dec; (14):198-215. PubMed ID: 16620405
    [No Abstract]   [Full Text] [Related]  

  • 19. Thromboprophylaxis in critically ill children: how should we define the "at risk" child?
    Parker RI
    Crit Care Med; 2011 Jul; 39(7):1846-7. PubMed ID: 21685760
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of LMW heparin: information for prescribers. Update: 10 April 2002].
    Agence Française de Sécurité Sanitaire Des Produits de Santé (AFSSAPS)
    J Mal Vasc; 2002 Oct; 27(4):231-3. PubMed ID: 12457130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.